The global sales of organ transport devices are estimated to be worth USD 478.0 million in 2025 and anticipated to reach a value of USD 735.8 million by 2035. Sales are projected to rise at a CAGR of 4.9% over the forecast period between 2025 and 2035. The revenue generated by organ transport devices in 2024 was USD 435.6 million.
Organ failure has reached an advanced stage in its progression, from end-stage renal disease (ESRD) through liver cirrhosis, heart failure, to chronic obstructive pulmonary disease (COPD) and end-stage kidney disease (ESKD), at which point a transplant is frequently the only way to treat a patient.
Again, chronic illnesses such as diabetes, hypertension, and cardiovascular disorders are also gradually causing more extensive organ damage leading to an enhanced need for organ transplantation. This increasing demand directly pushes for the need of efficient organ transport systems to guarantee the viability of organs during transport.
Global Organ Transport Devices Industry Outlook
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 435.6 million |
| Estimated Size, 2025 | USD 478.0 million |
| Projected Size, 2035 | USD 735.8 million |
| Value-based CAGR (2025 to 2035) | 4.9% |
According to Centers for Disease Control and Prevention statistics (2022), During 2000 to 2019, the number of ESKD cases reported in the United States increased 41.8%; the number of prevalent cases approximately doubled. Higher percentage changes in incident and prevalent ESKD cases were attributable to primary causes related to diabetes and hypertension.
Advances in healthcare have improved diagnostic capabilities, allowing early identification of organ dysfunction. This has expanded the pool of patients eligible for transplantation, further increasing the pressure on organ procurement and transportation infrastructure. In parallel, advances in medical science have improved organ preservation techniques, allowing longer transport times and a greater geographic reach of donor organs.
Moreover, the scarcity of donor organs in the world increases the need to make the best of any available organ. This shortage calls for highly credible organ transport systems that also support state-of-the-art preservation technologies that increase organ viability and expand transportation time. Without these devices, it becomes impossible to transfer organs over distance, which increases the distance between donor and recipient locations and chances of success of the transplantation.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The below table presents the expected CAGR for the global organ transport devices market over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2024 to 2035, the business is predicted to surge at a CAGR of 5.6%, followed by a slightly lower growth rate of 5.3% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.6% (2024 to 2035) |
| H2 | 5.3% (2024 to 2035) |
| H1 | 4.9% (2025 to 2035) |
| H2 | 4.4% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 4.9% in the first half and decrease moderately at 4.4% in the second half. In the first half (H1) the market witnessed a decrease of 70.00 BPS while in the second half (H2), the market witnessed an increase of 90.00 BPS.
Rising Organ Transplantation Rates Is Increasing the Need for Organ Transport Devices and Fueling the Market Growth.
Rising end-stage organ failure and chronic diseases have resulted in rapid growth in the number of organ transplantations being performed around the world. The following are the significant factors responsible for this increased incidence: demographic shifts, changes in lifestyle, and improved diagnostic acumen.
Not only an ageing population, but also rising incidences of chronic diseases, including diabetes, cardiovascular diseases, and kidney diseases, bring a group of individuals whose organ failure needs a lifesaving transplantation intervention.
According to Global Observatory on Donation and Transplantation, Globally, the number of organ transplants has also been on the rise. In 2022, there were 157,494 organs transplanted worldwide, representing a 9.1% increase over 2021
Progressively, the medical techniques of transplants also evolved, in terms of transplants becoming readily available, fast, and productive. Minimally invasive procedures, better algorithms for immunosuppressive treatments, and appropriate organ matching contributed significantly to further improved transplant outcome and survival results, thus creating healthy quality of life among recipients.
Organ transport devices range from the development of temperature-controlled containers to more advanced perfusion solutions that attempt to closely match physiological conditions, all designed to optimize organ preservation under various conditions. These are crucial for preserving organs during transit.
Driving Innovations by Manufacturers for Improved Transplant Outcomes is favoring the Growth for Organ Transport Devices Market
Many companies are actively implementing various methods to create dynamic advances within the organ transport devices industry, given the constantly changing nature of the industry. With the ultimate objective of promoting sales growth and expansion, these organizations place a high priority on initiating new product launches, obtaining product approvals, and developing product development activities.
TransMedics Group, Inc. is one noteworthy example of this proactive strategy; the company just reached a major milestone with the USA FDA premarket approval for their OCS Liver System in September 2021.
The vital necessity for efficient organ preservation after donation after cardiac death (DCD) and donation after brain death (DCBD) is addressed by this ground-breaking method. The OCS Liver System uses state-of-the-art technology to make it easier to preserve and monitor donor livers' hemodynamic and metabolic processes, allowing for thorough ex-vivo evaluation.
Organ transport technology has advanced significantly with the approval of the OCS Liver System, especially for liver allografts. Assessing and optimizing donor liver appropriateness for transplantation is made possible by the OCS Liver System's capacity to preserve organ viability and function outside of the body. This discovery helps meet the increasing need for donor organs while also improving the effectiveness and success rates of liver transplant operations.
Increasing Growing Transplantation Centers, a Significant Market Driver for Organ Transport Devices Market
The number of kidney transplants is increasing and in the year 2022, as stated by the United Network for Organ Sharing, it saw an increase of 16% in the United States. Transplant centers are growing rapidly. Also, clinics that provide transplantation services are also witnessing a sharp rise in transplant procedures.
According to its annual report for 2021, Cleveland Clinic Abu Dhabi had its busiest year for organ transplants, with 117 performed in a single year. Within a year, the flagship Hospitals accomplished 56 kidneys, 46 liver, and 5 pancreas transplants, as well as 3 heart and seven combination transplants.
Development in medical technology, increased public knowledge of the merits of transplantation, and easier accessibility to health care services are a few of the reasons driving this growth. Demand for organ transport devices to carry and preserve organs for transplantation surgery is increasing alongside the growth in transplantation centers.
This pattern emphasizes how crucial it is to have a strong infrastructure and effective organ transport options in order to support excellent transplant outcomes and meet the world's expanding organ transplant need.
Limited Availability of Donor Organs and Logistical Challenges Is Emerging as Significant Growth Barrier for Organ Transport Devices Market.
Shortages of donor organs and logistics complications severely impair organ transport device development and their efficacy in the execution of successful transplants. There is a severe shortage of donor organs chronic as compared to increasing demand for transplantation, thereby leaving huge challenges to health care providers as they deal with the growing demands of the patient population for such life-saving interventions.
The lack of appropriate donor organs is one of the main problems, which is caused by a number of variables such as low organ donation rates, strict donor requirements, and differences in organ distribution. Patients on transplant lists frequently have to wait long periods of time due to this shortage, which exacerbates their medical problems and raises mortality rates.
For instance, Machine perfusion emerges as a critical solution to expand the donor pool, yet its adoption faces challenges. Despite the potential to increase organ viability and utilization, logistical barriers and resource constraints hinder widespread implementation.
Furthermore, the underutilization of donor organs is made worse by differences in access to transplant treatments, especially in underprivileged or rural locations. Maximizing organ usage and improving transplant outcomes is further hampered by limited availability to specialized organ transport technologies and infrastructure in these places.
The global organ transport devices industry recorded a CAGR of 4.2% during the historical period between 2020 and 2024. The growth of organ transport devices industry was positive as it reached a value of USD 435.6 million in 2024 from USD 365.9 million in 2020.
The future of organ transport devices is going to be marked by breakthroughs aimed at improving organ viability, extending transport times, and enhancing logistical efficiency. Advanced perfusion technologies, which continuously oxygenate and provide nutrients to organs during transit, are one such innovation. These systems simulate physiological conditions, thus preserving the organs better and leading to higher success rates in transplantation.
The other critical advancement is the integration of IoT and smart monitoring capabilities. These devices will enable real-time tracking of critical parameters such as temperature, pressure, and perfusion flow rates, ensuring that organs remain in optimal condition throughout the journey. Predictive analytics powered by AI could also play a role, offering insights to preemptively address any potential issues during transport.
The biocompatibility as well as miniaturized components will make the usability and portability better for these devices so they can be used across health care settings. Next, innovations in cryopreservation and normothermic machine perfusion of organs will probably increase the shelf life of the available organs and allow them to be transported over longer distances, thereby increasing the organ-sharing networks reach. As a whole, the sales will collectively progress with these advances that ensure successful transplantation and save human lives.
Tier 1 companies comprise market leaders with a significant market share of 58.9% in global market. These companies engage in strategic partnerships and acquisitions to expand their product portfolios and access cutting-edge technologies. Additionally, they emphasize extensive clinical trials to validate the efficacy and safety of their products. Prominent companies in tier 1 include TrandMedis and XVIVO
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 21.9% market share. They typically pursue partnerships with multispecialty hospitals and research organizations to leverage emerging technologies and expedite product development.
These companies often emphasize agility and adaptability, allowing them to quickly bring new products to market, additionally targeting specific types medical needs. Additionally, they focus on cost-effective production methods to offer competitive pricing. Prominent companies in tier 2 include Organ Recovery Systems (ORS), Bridge to Life Ltd., Paragonix Technologies, Inc, OrganOx and others.
Finally, Tier 3 companies, such as Global Transplant Solutions, X-Therma, Inc., RipplePak, BTP Surgical LLC and others. They specialize in specific products and cater to niche markets, adding diversity to the industry. Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the organ transport devices sales remains dynamic and competitive.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the industry analysis for the organ transport devices market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle Ease & Africa, is provided. The United States is anticipated to remain at the forefront in North America, with higher market share through 2035. In South Asia & Pacific, India is projected to witness a CAGR of 4.0% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 4.7% |
| Germany | 5.5% |
| China | 7.9% |
| France | 6.3% |
| India | 7.4% |
| Spain | 8.6% |
| Australia & New Zealand | 5.1% |
| South Korea | 7.5% |
United States organ transport devices market is poised to exhibit a CAGR of 4.7% between 2025 and 2035. Currently, it holds the highest share in the North American market.
Since the USA performs the highest rate of organ transplants in the world, this, in fact, is a major push factor rising with the market for organ transport devices. Transplants occur mainly because of the well-established organ donation system and the increasing incidence of end-stage organ failure. This intensified demand for transplants thus warrants a purposely made-in-hand setup for the safe and efficient delivery of organs across the country.
Organ transport devices have played an important part in ensuring organ viability during transportation from a donor to a recipient, especially given the continental distances across the USA Healthcare providers are constantly on the lookout for innovative means of transport to solve the logistic problems inflicting the demand.
With increased operations for transplants, advanced preservation techniques, including perfusion systems and real-time monitoring devices, will amplify investment for the adoption of cutting-edge solutions, thereby further projecting market growth.
India organ transport devices market is poised to exhibit a CAGR of 7.4% between 2025 and 2035. Currently, it holds the highest share in the South Asia & Pacific market, and the trend is expected to continue during the forecast period.
The high patient cases requiring organ transplants significantly impact the growth rate of the market for organ transport devices. Because of the gigantic and increasing population that is afflicted increasingly with chronic disorders such as diabetes, hypertension, and liver, the demand for organs has seen immense growth. Hence, there exists a waiting list of growing size for the increase in number of patients to require kidney, liver, and other organ transplants.
The large patient pool requires effective and reliable transport systems to ensure that donated organs are preserved under optimal conditions during transit, especially in a vast country like India. The need for advanced transport devices is heightened because healthcare providers want to reduce the transplant rejection rate and improve the outcomes of the patients. This growing patient pool continues to drive the demand for innovative organ transport technologies in India.
Germany’s organ transport devices market is poised to exhibit a CAGR of 5.5% between 2025 and 2035. Currently, it holds the highest share in the Western Europe market, and the trend is expected to continue during the forecast period.
A robust regulatory framework is in place for organ transport devices market growth in Germany. It is a country that has an already established set of healthcare policies and regulations for the donation, transplantation, and transportation of organs. Therefore, it guarantees efficiency and transparency in the process. Organizations like the German Organ Transplantation Foundation (DSO) manage the procurement and distribution of organs to create a smooth system for allocation and transport of organs.
This regulatory structure fosters trust and efficiency in organ donation and transplantation, which directly boosts the demand for advanced organ transport devices. With a clear and standardized process, healthcare providers are more likely to adopt cutting-edge transport technologies to maintain organ viability during transit. The regulatory support ensures that these devices are used effectively, providing a conducive environment for their widespread adoption and contributing to the growth of the organ transport devices market in Germany.
The section contains information about the leading segments in the industry. By product, the devices segment holds the highest market share of 51.3% in 2025.
| By Product | Devices |
|---|---|
| Value Share (2025) | 51.3% |
The devices segment dominates the organ transport devices market due to the essential role these devices play in maintaining organ viability during transit. These devices, such as portable perfusion systems, cooling units, and advanced preservation machines, are critical for preventing organ damage by ensuring optimal conditions such as temperature control, oxygenation, and nutrient supply.
As the need for longer transportation times and organ sharing across regions increases, the reliance on these devices has grown. Their ability to preserve organs for extended periods has improved transplant success rates, driving their adoption. A robust regulatory framework is in place for organ transport devices market growth in Germany.
It is a country that has an already established set of healthcare policies and regulations for the donation, transplantation, and transportation of organs. Therefore, it guarantees efficiency and transparency in the process. Organizations like the German Organ Transplantation Foundation (DSO) manage the procurement and distribution of organs to create a smooth system for allocation and transport of organs.
| By End User | Hospitals |
|---|---|
| Value Share (2025) | 66.8% |
Hospitals have well-equipped specialized transplant units and skilled medical teams that manage the entire process of organ transplantation. The transplantation procedure requires very efficient systems to transport organs from one hospital to another while still preserving the viability of the organ.
Hospitals serve as procurement and recipient centers and coordinate organ donation and transplant patient admissions. Hospitals, therefore, stand at the top of organ transport requirements due to this central role. A hospital setting is required to ensure proper preservation, storage, and transportation, with trained staff and appropriate facilities for organ care. The need for sophisticated devices that guarantee the safe and effective transportation of organs in hospitals is enormous.
The market players are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Organ Transport Devices Market
In terms of product, the industry is divided into- devices, disposables, cold storage solution, perfusion solution and slush preparation solutions.
In terms of organ, the industry is segregated into- heart, lung, liver, kidney, pancreas, small bowel/intestine.
In terms of end user, the industry is segregated into- hospitals, transplant centers, organ procurement organizations (OPOs).
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
The global organ transport devices market is projected to witness CAGR of 4.9% between 2025 and 2035.
The global organ transport devices industry stood at USD 435.6 million in 2024.
The global organ transport devices market is anticipated to reach USD 735.8 million by 2035 end.
India is set to record the highest CAGR of 7.4% in the assessment period.
The key players operating in the global organ transport devices market include Bridge to Life Ltd., TransMedics, Paragonix Technologies, Inc, XVIVO, OrganOx, Organ Recovery Systems (ORS), X-Therma, Inc., Global Transplant Solutions, RipplePak and Vascular Perfusion Solutions, Inc.
Explore Medical Supplies Insights
View Reports
Organ Transport Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
